FDA okays more biotechnology products

被引：0

作者：

不详

机构：

来源：

BIOTECHNOLOGY LAW REPORT | 1997年 / 16卷 / 03期

关键词：

anticoagulants; Bard Diagnostic; bladder cancer; blood banks; haemonetics; international technidyne; osteoset bone graft substitute; Wright medical technologies;

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：353 / 354

页数：2

共 50 条

[31] ALL PARTIES DELIGHTED - CONGRESS OKAYS FDA USER FEES
FOX, JL
[J]. BIO-TECHNOLOGY, 1992, 10 (11): : 1409 - 1409
[32] FDA proposes elimination of establishment licenses for ''well-characterized biotechnology products''
Cohen, MR
[J]. BIOTECHNOLOGY LAW REPORT, 1996, 15 (02): : 197 - 200
[33] FDA OKAYS INTERFERON-BETA FOR MULTIPLE-SCLEROSIS
THAYER, A
[J]. CHEMICAL & ENGINEERING NEWS, 1993, 71 (31) : 5 - 6
[34] FDA ADVISORY PANEL OKAYS INTERFERON-BETA FOR MS
FOX, JL
[J]. BIO-TECHNOLOGY, 1993, 11 (05): : 538 - 539
[35] Two more biotechnology products receive orphan drug designation
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1999, 18 (05) : 407 - 408
[36] Two more biotechnology products receive orphan drug designation
不详
[J]. BIOTECHNOLOGY LAW REPORT, 2000, 19 (04) : 417 - 417
[37] FDA Committee: More Restrictions Needed on Hydrocodone Combination Products
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (09): : 862 - 862
[38] FDA adds more tainted weight loss products to list
[J]. Reactions Weekly, 2009, 1245 (1) : 2 - 2
[39] FDA okays phosphorus-binding polymer for patients in renal failure
不详
[J]. BIOTECHNOLOGY LAW REPORT, 1999, 18 (01) : 42 - 42
[40] FDA Okays First Drug for Scarring From Fatty Liver Disease
Harris, Emily
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (17):

← 1 2 3 4 5 →